EUVIMEDEUVIMED entdecken
Crossref

Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomy

Sarah Alessi, Roberta Maggioni, Stefano Luzzago, Paul E Summers, Giuseppe Renne, Fabio Zugni, Maddalena Belmonte, Sara Raimondi, Silvano Vignati, Francesco A Mistretta, Letizia Di Meglio, Elisa D'Ascoli und 7 weitere

La radiologia medica · 2024

DOI: 10.1007/s11547-024-01857-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, 2024. Verfasst von Sarah Alessi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy. sarah.alessi@ieo.it. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Neoplasm Recurrence, Local, Multiparametric Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess the ability of tumor apparent diffusion coefficient (ADC) values obtained from multiparametric magnetic resonance imaging (mpMRI) to predict the risk of 5-year biochemical recurrence (BCR) after radical prostatectomy (RP). MATERIALS AND METHODS: This retrospective analysis included 1207 peripheral and 232 non-peripheral zone prostate cancer (PCa) patients who underwent mpMRI before RP (2012-2015), with the outcome of interest being 5-year BCR. ADC was evaluated as a continuous variable and as categories: low ( 1100 µm2/s). Kaplan-Meier curves with log-rank testing of BCR-free survival, multivariable Cox proportional hazard regression models were formed to estimate the risk of BCR. RESULTS: Among the 1439 males with median age 63 (± 7) years, the median follow-up was 59 months, and 306 (25%) patients experienced BCR. Peripheral zone PCa patients with BCR had lower tumor ADC values than those without BCR (874 versus 1025 µm2/s, p < 0.001). Five-year BCR-free survival rates were 52.3%, 74.4%, and 87% for patients in the low, intermediate, and high ADC value categories, respectively (p < 0.0001). Lower ADC was associated with BCR, both as continuously coded variable (HR: 5.35; p < 0.001) and as ADC categories (intermediate versus high ADC-HR: 1.56, p = 0.017; low vs. high ADC-HR; 2.36, p < 0.001). In the non-peripheral zone PCa patients, no association between ADC and BCR was observed. CONCLUSION: Tumor ADC values and categories were found to be predictive of the 5-year BCR risk after RP in patients with peripheral zone PCa and may serve as a prognostic biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyProstatic NeoplasmsNeoplasm Recurrence, LocalMultiparametric Magnetic Resonance ImagingHumansMaleMiddle AgedRetrospective StudiesAgedProstate-Specific AntigenRisk AssessmentDiffusion Magnetic Resonance Imaging

Stichwörter der Autor:innen

Apparent diffusion coefficientBiochemical recurrenceMultiparametric prostate MRIProstate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Division of Radiology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy. sarah.alessi@ieo.it.
  • Division of Radiology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
  • Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy.
  • Division of Uropathology and Intraoperative Diagnostic Division, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
  • Molecular and Pharmaco-Epidemiology Unit Department of Experimental Oncology IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Alessi, S., Maggioni, R., Luzzago, S., Summers, P. E., Renne, G., Zugni, F., Belmonte, M., Raimondi, S., Vignati, S., Mistretta, F. A., Di Meglio, L., D'Ascoli, E., Scarabelli, A., Marvaso, G., De Cobelli, O., Musi, G., Jereczek-Fossa, B. A., Curigliano, G., & Petralia, G. (2024). Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomy. La radiologia medica. https://doi.org/10.1007/s11547-024-01857-0

Vancouver

Alessi S, Maggioni R, Luzzago S, Summers PE, Renne G, Zugni F, et al. Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomy. La radiologia medica. 2024. doi:10.1007/s11547-024-01857-0

BibTeX
@article{Alessi2024,
  author = {Alessi, Sarah and Maggioni, Roberta and Luzzago, Stefano and Summers, Paul E and Renne, Giuseppe and Zugni, Fabio and Belmonte, Maddalena and Raimondi, Sara and Vignati, Silvano and Mistretta, Francesco A and Di Meglio, Letizia and D'Ascoli, Elisa and Scarabelli, Alice and Marvaso, Giulia and De Cobelli, Ottavio and Musi, Gennaro and Jereczek-Fossa, Barbara Alicja and Curigliano, Giuseppe and Petralia, Giuseppe},
  title = {Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomy},
  journal = {La radiologia medica},
  year = {2024},
  doi = {10.1007/s11547-024-01857-0}
}
Kostenlos starten →